Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06341166 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse

Study acronym: SCIMITAR
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Jun 19, 2026 → Oct 19, 2026
See other at-risk trials from Centro Cardiologico Monzino

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jun 19, 2026 to Oct 19, 2026
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 6 of 6 entries
  2. Primary and study completion dates: Jun 19, 2025 to Jun 19, 2026v3
  3. Secondary endpoints: 1 to 6
    • Site details revised
    • Collaborators revised (3)
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multicenter, observational prospective and retrospective study which aims are: 1) to compute a scoring model potentially predictive for the diagnosis of fibrosis by CMR in patients with MVP; 2) to identify specific features that may predispose to ≥ mild VAs or SCD in patients with MVP.
Trial Details
NCT Number NCT06341166
Lead Sponsor Centro Cardiologico Monzino
Collaborators: Humanitas Hospital, Italy, IRCCS Ospedale San Raffaele, Azienda Ulss 2 Marca Trevigiana
Conditions
(from sponsor)		 Mitral Valve Prolapse
Related terms Mitral Valve Prolapse
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov